Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation.
Saved in:
| Title: | Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation. |
|---|---|
| Authors: | Corneli A; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC, 27701, USA. amy.corneli@duke.edu.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. amy.corneli@duke.edu.; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. amy.corneli@duke.edu., Perry B; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC, 27701, USA., Des Marais A; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC, 27701, USA., Choi Y; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC, 27701, USA., Chen H; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC, 27701, USA., Lilly R; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.; Port City Harm Reduction, Wilmington, NC, USA., Ayers D; Queen City Harm Reduction, Charlotte, NC, USA., Bennett J; North Carolina Harm Reduction Coalition, Wilmington, NC, USA., Kestner L; Queen City Harm Reduction, Charlotte, NC, USA., Meade CS; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA., Sachdeva N; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC, 27701, USA.; North Carolina Association of County Commissioners, Raleigh, NC, USA., McKellar MS; Department of Medicine, Duke University School of Medicine, Durham, NC, USA. |
| Source: | Harm reduction journal [Harm Reduct J] 2022 Dec 03; Vol. 19 (1), pp. 132. Date of Electronic Publication: 2022 Dec 03. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
